CENTRUM MEDYCZNE HOPE CLINIC
- Address
- Nałęczowska 18/159, 20-701 Lublin, Poland
Neurology and Neuroimmunology
CENTRUM MEDYCZNE HOPE CLINIC in Lublin is actively involved in neurology and immune system disease research, with studies focused on conditions such as generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and multiple sclerosis. These trials are designed to evaluate new treatment options, monitor longer-term safety, and improve control of relapsing or disabling symptoms.
- Generalized myasthenia gravis studies assessing new therapies for muscle weakness and daily function
- Chronic inflammatory demyelinating polyneuropathy research aimed at maintaining response and limiting relapse
- Multiple sclerosis trials comparing treatments to reduce relapse frequency
- Myasthenia gravis programs evaluating symptom improvement and treatment durability
Overall, the site contributes to research that seeks better disease control, safer long-term care, and improved quality of life for people living with complex neurological and autoimmune disorders.
Headache and Pain Research
The clinic also supports a strong portfolio in nervous system diseases and pain-related care, especially migraine and diabetic peripheral neuropathic pain. The research here is centered on testing preventive and symptom-relief approaches that may reduce headache burden and ease chronic pain.
- Chronic migraine and episodic migraine studies focused on prevention and fewer headache days
- Diabetic peripheral neuropathic pain trials exploring new ways to reduce persistent nerve pain
- Chronic pain due to diabetic peripheral neuropathy research evaluating treatment effectiveness
- Patient-centered studies looking at day-to-day symptom relief and functional improvement
These trials aim to identify options that are easier to live with and more effective for people whose pain or migraines have not responded well to standard care.
Endocrine and Eye Disease Studies
Research at CENTRUM MEDYCZNE HOPE CLINIC includes conditions where the immune system affects the eyes and thyroid, with work in thyroid eye disease and Graves’ disease. This area of study is mainly focused on testing therapies that may improve visible eye symptoms, support thyroid balance, and maintain disease control over time.
- Thyroid eye disease trials examining changes in eye-related symptoms such as proptosis
- Graves’ disease studies evaluating control of thyroid function and relapse prevention
- Eye disease research aimed at improving comfort, appearance, and daily functioning
The goal is to expand treatment choices for patients with autoimmune thyroid-related conditions that can affect both vision and overall well-being.
Behavioral Health and Smoking Cessation
The site’s psychiatry and psychology research includes behavioral support studies, with a notable focus on electronic cigarette cessation. These trials explore practical ways to help people stop vaping or using tobacco-related products, combining medication support with counseling-based strategies.
- Electronic cigarette cessation research for people motivated to quit vaping
- Behavioral support studies examining abstinence and long-term quitting success
- Public-health-oriented work addressing nicotine dependence and dual use of vaping and smoking
This area highlights a broader interest in behavior change research that can support healthier habits and reduce nicotine exposure.
Infectious and Women’s Health Research
In the area of bacterial infections and mycoses, the clinic is involved in studies on bacterial vaginosis, a common condition affecting women’s health. The research is aimed at comparing treatment approaches and improving effectiveness for infection control.
- Bacterial vaginosis studies comparing treatment effectiveness
- Women’s health research focused on symptom relief and infection resolution
- Clinical work evaluating better options for common bacterial conditions
This area adds an important infectious disease and gynecologic dimension to the site’s clinical trial portfolio.
Oncology and Other Specialized Studies
The research portfolio also includes neoplasms, with studies in thoracic tumors with homozygous MTAP-deletion. Alongside this, the site is contributing to broader specialized research that tests new treatment strategies for difficult-to-treat conditions.
- Thoracic tumors with homozygous MTAP-deletion studies exploring new cancer treatment approaches
- Specialized oncology research aimed at advancing care for patients with advanced disease
- Trials designed to assess whether emerging therapies can improve treatment response
This work shows that the site’s clinical research extends beyond common chronic diseases into targeted investigations for selected cancer populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Immunovant Sciences GmbH1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Immunovant Sciences GmbH5trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CENTRUM MEDYCZNE HOPE CLINIC
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM]) | Amgen Inc. | Phase III | Not Recruiting | Jul 2019 | Jan 2026 |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Batoclimab | 4 | Unknown | 2023-06-27 | 2025-05-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
